MyBlueDots

Antibody therapy shrinks immunotherapy-resistant lung cancer tumors in mice

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging an attack from natural killer (NK) cells in an animal model, a study led by UT Southwestern Medical Center researchers shows. The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to new types of immunotherapy that rely on this novel strategy.
Read More

Multisociety taskforce develops new standards to monitor adults with heart valve disease

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 patient-centered outcome measures for people with heart valve disease, regardless of treatment (surgical or transcatheter procedure), according to a new report published today in the journal Circulation: Cardiovascular Quality & Outcomes.
Read More

Frailty score could reduce pressure on hospital beds and lower costs

The Hospital Frailty Risk Score (HFRS) helps identify older patients (aged 75 and over) who may be frail and more likely to experience poor outcomes during or after a hospital stay. New research, led by the University of Portsmouth in collaboration with Portsmouth Hospitals University NHS Trust, has found the HFRS is effective at predicting extended hospital stays in patients of all ages—not just older adults.
Read More
Top